Table 3.
Drug list for ATP-TCA with manufacturer, given with the 100% test drug concentration (TDC) used in the assay, and the number of tumors tested.
| Drug or combination | Manufacturer | TDC (μM) | Number tested |
|---|---|---|---|
| Docetaxel | Sanofi-Aventis | 3.00 | 43 |
| Cisplatin | Bristol-Myers-Squibb | 10.00 | 41 |
| Gemcitabine | Eli Lilly | 40.04 | 39 |
| Cisplatin with Gemcitabine | As single agents | As single agents | 38 |
| Docetaxel with Cisplatin | As single agents | As single agents | 22 |
| Docetaxel with Gemcitabine | As single agents | As single agents | 21 |
Some tumors had too few cells for all agents/combinations to be tested.